Further analysis of protein expression using Clinical Proteomic Tumor Analysis Consortium (CPTAC) database revealed a similar progressive decrease in claudin-2 protein expression with RCC progression (Fig. 1b). This evidence concerns the gene CLDN2 and neoplasm.